SARS-CoV-2 infection induces expression and secretion of lipocalin-2 and regulates iron in a human lung cancer xenograft model

키워드

참고문헌 (40)

1. Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
2. Letko M, "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses", Nat Microbiol, 5, pp.562~569 (2020)
3. Lauer SA, "The incubation period of coronavirus disease 2019(COVID-19)from publicly reported confirmed cases : estimation and application", Ann Intern Med, 172, pp.577~582 (2020)
4. Wang Y, "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia(COVID-19)implicate special control measures", J Med Virol, 92, pp.568~576 (2020)
5. Bergamaschi G, "Anemia in patients with COVID-19 : pathogenesis and clinical significance", Clin Exp Med, 21, pp.239~246 (2021)
6. Triebel S, "A 25Kda alpha-2-microglobulin-related protein is a component of the 125-Kda form of human gelatinase", FEBS Lett, 314, pp.386~388 (1992)
7. Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
8. Behairy Bel S, "Lipocalin-2 as a marker of bacterial infections in chronic liver disease : a study in Egyptian children", Egypt J Immunol, 18, pp.31~36 (2011)
9. Thanh TT, "Value of lipocalin 2 as a potential biomarker for bacterial meningitis", Clin Microbiol Infect, 27, pp.724~730 (2021)
10. Wilson R, "Proteomic characterization of mouse cartilage degradation in vitro", Arthritis Rheum, 58, pp.3120~3131 (2008)
11. Bolignano D, "Neutrophil gelatinase-associated lipocalin(NGAL)as a marker of kidney damage", Am J Kidney Dis, 52, pp.595~605 (2008)
12. Chakraborty S, "The multifaceted roles of neutrophil gelatinase associated lipocalin(NGAL)in inflammation and cancer", Biochim Biophys Acta, 1826, pp.129~169 (2012)
13. Jang Y, "Emerging clinical and experimental evidence for the role of lipocalin-2in metabolic syndrome", Clin Exp Pharmacol Physiol, 39, pp.194~199 (2012)
14. Berard JL, "Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis", Glia, 60, pp.1145~1159 (2012)
15. Asimakopoulou A, "Lipocalin 2(LCN2)Expression in hepatic malfunction and therapy", Front Physiol, 7, pp.430~ (2016)
16. Hu C, "Lipocalin 2 : a potential therapeutic target for breast cancer metastasis", Onco Targets Ther, 11, pp.8099~8106 (2018)
17. Chaudhary N, "Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer", Int J Cancer, 149, pp.1495~1511 (2021)
18. Landro L, "Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients : increase during highly active anti-retroviral therapy", Clin Exp Immunol, 152, pp.57~63 (2008)
19. Abers MS, "An immune-based biomarker signature is associated with mortality in COVID-19 patients", Jci Insight, 6, pp.e144455~ (2021)
20. He L, "Incorporation of urinary neutrophil gelatinase-associated lipocalin and computed tomography quantification to predict acute kidney injury and in-hospital death in COVID-19 patients", Kidney Dis(Basel), 7, pp.120~130 (2021)
21. Gupta A, "Lipocalin-2, S100A8", A9, and cystatin C : potential predictive biomarkers of cardiovascular complications in COVID-19, 2022, pp.247, 1205~1213
22. Miharada K, "Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion", FASEB J, 19, pp.1881~1883 (2005)
23. Jiang W, "Anemia upregulates lipocalin 2 in the liver and serum", Blood Cells Mol Dis, 41, pp.169~174 (2008)
24. Suriawinata E, "Iron and iron-related proteins in COVID-19", Clin Exp Med, 23, pp.969~991 (2022)
25. Neufeldt CJ, "SARSCoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-kappaB", Commun Biol, 5, pp.45~ (2022)
26. Blanco-Melo D, "Imbalanced host response to SARS-CoV-2 drives development of COVID-19", Cell, 181, pp.1036~1045 (2020)
27. Saber MM, "Endothelial monocyte-activating polypeptide-ii is an indicator of severity and mortality in COVID-19 patients", Vaccines(Basel), 10, pp.2177~ (2022)
28. Mueller CA, "Accumulation of the proinflammatory cytokine endothelial-monocyte-activating polypeptide II in ramified microglial cells in brains of Borna virus infected Lewis rats", Neurosci Lett, 339, pp.215~218 (2003)
29. Dongbum Kim, "MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection", BMB Reports, 54(8), pp.425~430 (2021), 생화학분자생물학회
30. Kim J, "Targeting the interaction between spike protein and nucleocapsid protein for suppression and detection of human coronavirus OC43", Front Immunol, 13, pp.835333~ (2022)
31. Sanjuan R, "Mechanisms of viral mutation", Cell Mol Life Sci, 73, pp.4433~4448 (2016)
32. Kim D, "Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2", Front Cell Infect Microbiol, 13, pp.1280686~ (2023)
33. Schmidt-Ott KM, "Dual action of neutrophil gelatinase-associated lipocalin", J Am Soc Nephrol, 18, pp.407~413 (2007)
34. Devireddy LR, "A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake", Cell, 123, pp.1293~1305 (2005)
35. Choi JW, "Elevated plasma neutrophil gelatinase-associated lipocalin level as a risk factor for anemia in patients with systemic inflammation", Biomed Res Int, 2016, pp.9195219~ (2016)
36. Bolignano D, "Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?", Med Sci Monit, 16, pp.RA131~RA135 (2010)
37. Rodrigues PN, "Mycobacteria-induced anaemia revisited : a molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin", Immunobiology, 216, pp.1127~1134 (2011)
38. Chavda VP, "SARSCoV-2 variants and vulnerability at the global level", J Med Virol, 94, pp.2986~3005 (2022)
39. Yang Z, "Clinical characteristics, transmissibility, pathogenicity, susceptible populations, and re-infectivity of prominent COVID-19 variants", Aging Dis, 13, pp.402~422 (2022)
40. "Historical working definitions and primary actions for SARS-CoV-2 variants" (2023)[URL]

관련 논문AI추천